Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians.

ABSTRACT:

Background

Most people with opioid use disorder (OUD) are not treated with FDA-approved medications methadone, buprenorphine, or naltrexone. Expanding capacity for evidence-based OUD medication in primary care is a national priority. No studies have examined primary care trainee physicians' attitudes about these medications. This study surveyed a national sample of primary care trainee physicians and compared their views with those of primary care attending physicians (i.e., those who have completed training).

Methods

Random samples of 1,000 trainee physicians and 1,000 attending physicians specializing in family, internal, or general medicine were selected from the American Medical Association Masterfile. Surveys were mailed February-August 2019. 45 % of eligible trainee ph

SUBMITTER: Kennedy-Hendricks A 

PROVIDER: S-EPMC7609519 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature